Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations (Q34552571)

3 August 2017

1 reference

title

Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations (English)

1 reference

3 August 2017

1 reference

1 reference

3

Martin B Leon

1 reference

3 August 2017

Alexandra J Lansky

1

1 reference

3 August 2017

Kartik Desai

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

American Journal of Cardiology

3 August 2017

published in

1 reference

3 August 2017

volume

89

1 reference

3 August 2017

issue

4A

1 reference

3 August 2017

page(s)

4B-9B

1 reference

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Observer agreement in evaluating coronary angiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Reproducibility of a consensus panel in the interpretation of coronary angiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Accuracy of individual and panel visual interpretations of coronary arteriograms: implications for clinical decisions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Variability in the analysis of coronary arteriograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Reliability of assessing change with sequential coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

A new digital electronic caliper for measurement of coronary arterial stenosis: comparison with visual estimates and computer-assisted measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Comparison of automated quantitative coronary angiography with caliper measurements of percent diameter stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factor intervention trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Comparison of three methods of evaluating coronary obstructive lesions: postmortem arteriography, pathologic examination and measurement of regional myocardium perfusion during maximal vasodilation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Variability in measures of coronary lumen dimensions using quantitative coronary angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

Accuracy and precision of quantitative digital coronary arteriography: observer-, short-, and medium-term variabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902326-8

10.1016/S0002-9149(01)02326-8

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference